Attorney General
Here's a look at documents from state attorneys general
Featured Stories
Nebraska Attorney General's Office Announces Settlements with Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition
LINCOLN, Nebraska, Feb. 2 -- Nebraska Attorney General Mike Hilgers issued the following news release:
* * *
Nebraska Attorney General's Office Announces Settlements with Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition
*
Lincoln -The Nebraska Attorney General's Office joined a coalition of 48 states and territories announcing two settlements with Lannett Company, Inc. ("Lannett") and Bausch Health US, LLC and Bausch Health Americas, Inc. ("Bausch"), totaling $17.85 million to resolve allegations that both companies engaged in widespread,
... Show Full Article
LINCOLN, Nebraska, Feb. 2 -- Nebraska Attorney General Mike Hilgers issued the following news release:
* * *
Nebraska Attorney General's Office Announces Settlements with Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition
*
Lincoln -The Nebraska Attorney General's Office joined a coalition of 48 states and territories announcing two settlements with Lannett Company, Inc. ("Lannett") and Bausch Health US, LLC and Bausch Health Americas, Inc. ("Bausch"), totaling $17.85 million to resolve allegations that both companies engaged in widespread,long-running conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs.
As part of their settlement agreements, both companies have agreed to cooperate in the ongoing multistate litigations led by Connecticut against 30 corporate defendants and 25 individual executives. Both companies have further agreed to a series of internal reforms to ensure fair competition and compliance with antitrust laws.
The Lannett and Bausch settlements follow prior settlements with Apotex and Heritage, which totaled $49.1 million.
These settlements come as the States prepare for the first trial to be held in Hartford, Connecticut, and are anticipated to be scheduled in late 2026.
If you purchased a generic prescription drug manufactured by either Lannett or Bausch between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com.
States and territories settling today with Lannett and Bausch include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
***
Original text here: https://ago.nebraska.gov/news/nebraska-attorney-generals-office-announces-settlements-lannett-and-bausch-totaling-1785
Attorney General Tong Announces Settlements With Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition, Announces New Complaint Against Novartis, Sandoz AG and Sandoz Group AG
HARTFORD, Connecticut, Feb. 2 -- Connecticut Attorney General William Tong issued the following news release:
* * *
Attorney General Tong Announces Settlements With Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition, Announces New Complaint Against Novartis, Sandoz AG and Sandoz Group AG
*
If You Bought Certain Generic Prescription Drugs in the United States Between May 1, 2009 and December 31, 2019, You Could be Eligible for Money
(Hartford, CT) - Attorney General William Tong today led a coalition of 48 states and territories announcing
... Show Full Article
HARTFORD, Connecticut, Feb. 2 -- Connecticut Attorney General William Tong issued the following news release:
* * *
Attorney General Tong Announces Settlements With Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition, Announces New Complaint Against Novartis, Sandoz AG and Sandoz Group AG
*
If You Bought Certain Generic Prescription Drugs in the United States Between May 1, 2009 and December 31, 2019, You Could be Eligible for Money
(Hartford, CT) - Attorney General William Tong today led a coalition of 48 states and territories announcingtwo settlements with Lannett Company, Inc. ("Lannett") and Bausch Health US, LLC and Bausch Health Americas, Inc. ("Bausch"), totaling $17.85 million to resolve allegations that both companies engaged in widespread, long-running conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. As part of their settlement agreements, both companies have agreed to cooperate in the ongoing multistate litigations led by Connecticut against 30 corporate defendants and 25 individual executives. Both companies have further agreed to a series of internal reforms to ensure fair competition and compliance with antitrust laws.
The Lannett and Bausch settlements follow prior settlements with Apotex and Heritage which totaled $49.1 million.
These settlements come as the States prepare for the first trial to be held in Hartford, Connecticut and anticipated to be scheduled in late 2026.
If you purchased a generic prescription drug manufactured by either Lannett or Bausch between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
Also today, 42 states and territories will file a new lawsuit against Novartis and its subsidiaries Sandoz Group AG and Sandoz AG alleging a systemic campaign to conspire with other generic manufacturers to fix prices, allocate markets, and rig bids for 31 different generic drugs. The complaint further alleges that Novartis took steps to fraudulently transfer and drain assets from Sandoz, Inc., a defendant in the three previously filed state antitrust complaints, and spin off Sandoz, Inc. to shield Novartis from liability.
"Lannett and Bausch both engaged in widespread conspiracies to jack up prices and block competition for generic prescription drugs. Their brazen collusion cost American families and our public healthcare programs millions of dollars. Both companies are now cooperating with our ongoing litigation. Also today, we will file a new complaint against Novartis and its subsidiaries to stop the company from fraudulently shielding assets to evade accountability. We continue to aggressively pursue this case and are very confident heading toward our first trial in Connecticut," said Attorney General Tong.
Connecticut's Attorney General Office is leading a coalition of nearly all states and territories in a series of antitrust cases, starting first in 2016 under the leadership of then-Attorney General George Jepsen. The first Complaint included Heritage and 17 other corporate Defendants, two individual Defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have since entered into settlement agreements and are cooperating. The second Complaint was filed in 2019 against Teva Pharmaceuticals and 19 of the nation's largest generic drug manufacturers. The Complaint names 16 individual senior executive Defendants. The third complaint, to be tried first, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and names 26 corporate defendants and 10 individual defendants. Seven additional pharmaceutical executives have entered into settlement agreements with the States and have been cooperating to support the States' claims.
The cases all stem from a series of investigations built on evidence from several cooperating witnesses at the core of the different conspiracies, a massive document database of over 20 million documents, and a phone records database containing millions of call detail records and contact information for over 600 sales and pricing individuals in the generics industry. Each complaint addresses a different set of drugs and defendants, and lays out an interconnected web of industry executives where these competitors met with each other during industry dinners, "girls nights out", lunches, cocktail parties, golf outings and communicated via frequent telephone calls, emails and text messages that sowed the seeds for their illegal agreements. Throughout the complaints, defendants use terms like "fair share," "playing nice in the sandbox," and "responsible competitor" to describe how they unlawfully discouraged competition, raised prices and enforced an ingrained culture of collusion. Among the records obtained by the States is a two-volume notebook containing the contemporaneous notes of one of the States' cooperators that memorialized his discussions during phone calls with competitors and internal company meetings over a period of several years.
States and territories settling today with Lannett and Bausch include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
States and territories filing the new complaint against Novartis, Sandoz AG and Sandoz Group AG include: Alaska, Arizona, California, Connecticut, Colorado, Delaware, District of Columbia, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Dakota, Tennessee, Vermont, U.S. Virgin Islands, Virginia, Washington, West Viginia, Wisconsin, and Wyoming.
Twitter: @AGWilliamTong
Facebook: CT Attorney General
Media Contact:
Elizabeth Benton
elizabeth.benton@ct.gov
Consumer Inquiries:
860-808-5318
attorney.general@ct.gov
***
Original text here: https://portal.ct.gov/ag/press-releases/2026-press-releases/attorney-general-tong-announces-settlements-with-lannett-and-bausch
Attorney General James Secures More Than $17 Million from Drug Manufacturers Bausch and Lannett for Conspiracy to Inflate Prices
ALBANY, New York, Feb. 2 -- New York Attorney General Letitia James issued the following news release:
* * *
Attorney General James Secures More Than $17 Million from Drug Manufacturers Bausch and Lannett for Conspiracy to Inflate Prices
*
February 2, 2026
NEW YORK - New York Attorney General Letitia James today joined a bipartisan coalition of 47 other attorneys general in securing $17.85 million from drug companies Bausch and Lannett for their role in a massive, long-running scheme to inflate prices of generic drugs and reduce competition. The new settlements are part of an ongoing multistate
... Show Full Article
ALBANY, New York, Feb. 2 -- New York Attorney General Letitia James issued the following news release:
* * *
Attorney General James Secures More Than $17 Million from Drug Manufacturers Bausch and Lannett for Conspiracy to Inflate Prices
*
February 2, 2026
NEW YORK - New York Attorney General Letitia James today joined a bipartisan coalition of 47 other attorneys general in securing $17.85 million from drug companies Bausch and Lannett for their role in a massive, long-running scheme to inflate prices of generic drugs and reduce competition. The new settlements are part of an ongoing multistatelitigation against dozens of companies for illegal agreements to fix prices for generic drugs. The companies in the scheme, some of which increased prices by 1,000 percent, manufactured essential medications to treat diseases ranging from diabetes to cancer to ADHD. Attorney General James is encouraging all New Yorkers who may have faced higher prices to register on the settlement website, check their eligibility, and submit a claim to seek compensation when the claims process begins.
"Access to affordable prescription drugs is a necessity for millions of New Yorkers," said Attorney General James. "After dozens of drug companies colluded behind the scenes to raise costs for consumers, my office is taking action to hold them accountable and get consumers their money back. I urge any New Yorker who may have been cheated by this scheme to submit their information to claim the restitution they are owed."
New Yorkers who purchased a generic prescription drug listed here between May 2009 and December 2019 may be eligible for compensation. Consumers can determine their eligibility by calling 1-866-290-0182, emailing info@AGGenericDrugs.com, or visiting www.AGGenericDrugs.com.
The settlements are the result of three lawsuits filed by the Office of the Attorney General (OAG) and a coalition of attorneys general against some of the nation's largest generic pharmaceutical companies. The first complaint included 18 corporate defendants, two individual defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have since entered into settlement agreements and are cooperating. The second complaint was filed in 2019 against Teva Pharmaceuticals and 19 of the nation's largest generic drug manufacturers. The complaint names 16 individual senior executive defendants. The third complaint, to be tried first, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and names 26 corporate defendants and 10 individual defendants. Six additional pharmaceutical executives have entered into settlement agreements with the coalition of attorneys general and have been cooperating to support the states' claims in all three cases.
The lawsuits allege these companies engaged in a broad, coordinated, and systematic conspiracy to fix prices, avoid competition, and rig bids for more than 100 different generic drugs. The companies maintained an interconnected web of industry executives where these competitors met with each other during industry dinners, "girls' nights out," lunches, cocktail parties, and golf outings, and communicated via frequent telephone calls, emails, and text messages that formed the basis for their illegal agreements. Defendants used terms like "fair share," "playing nice in the sandbox," and "responsible competitor" to describe how they unlawfully discouraged competition, raised prices, and enforced an ingrained culture of collusion.
The drugs included in the scheme span all types - including tablets, capsules, creams, and ointments - and classes - including antibiotics, anti-depressants, contraceptives, and non-steroidal anti-inflammatory drugs. They treat a range of diseases and conditions from basic infections to diabetes, cancer, epilepsy, multiple sclerosis, HIV, ADHD, and more. In some instances, the coordinated price increases were over 1,000 percent. For example, Digoxin, an essential heart medication manufactured by Heritage, tripled in price, causing patients to pay hundreds of dollars more for the drug.
Lannett will pay $13,770,000 and Bausch will pay $4,080,000 under the two settlements, which will be distributed to impacted consumers across the coalition states. The companies will also implement internal reforms to ensure fair competition and compliance with antitrust laws, including implementing an Antitrust Compliance Program with annual training of sales and management staff.
This is the latest settlement secured by Attorney General James and the coalition. In November 2024, Attorney General James and the coalition secured $49.1 million from Apotex and Heritage. As part of the settlement, both Apotex and Heritage will cooperate in the ongoing multistate lawsuits against 30 corporate defendants and 25 individual executives. Both companies will also make internal reforms to ensure fair competition and compliance with antitrust laws.
Joining Attorney General James in securing the settlements are the attorneys general of Alaska, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, the District of Columbia, Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands.
New York's investigation has been led by Assistant Attorneys General Bob Hubbard, Saami Zain, Izzy Pitt and Ben Cole, and Legal Assistant Arlene Leventhal, under the supervision of Deputy Bureau Chief Amy McFarlane and Bureau Chief Elinor Hoffmann of the Antitrust Bureau. The Antitrust Bureau is part of the Division for Economic Justice, overseen by Chief Deputy Attorney General Christopher D'Angelo and First Deputy Attorney General Jennifer Levy.
***
Original text here: https://ag.ny.gov/press-release/2026/attorney-general-james-secures-more-17-million-drug-manufacturers-bausch-and
Attorney General Alan Wilson opposes government-mandated COVID vaccinations
COLUMBIA, South Carolina, Feb. 2 -- South Carolina Attorney General Alan Wilson issued the following news:
* * *
Attorney General Alan Wilson opposes government-mandated COVID vaccinations
*
(COLUMBIA, S.C.) - Attorney General Alan Wilson joined a 13-state friend-of-the-court brief to protect the right of South Carolinians to be free from government-mandated COVID vaccines.
"Since 2020, we have seen a concerted push to curtail personal liberty in the name of health and safety," Attorney General Wilson said. "Personal liberty and the sacred right to be free from compelled bodily intrusion
... Show Full Article
COLUMBIA, South Carolina, Feb. 2 -- South Carolina Attorney General Alan Wilson issued the following news:
* * *
Attorney General Alan Wilson opposes government-mandated COVID vaccinations
*
(COLUMBIA, S.C.) - Attorney General Alan Wilson joined a 13-state friend-of-the-court brief to protect the right of South Carolinians to be free from government-mandated COVID vaccines.
"Since 2020, we have seen a concerted push to curtail personal liberty in the name of health and safety," Attorney General Wilson said. "Personal liberty and the sacred right to be free from compelled bodily intrusionis at the heart of the American experiment."
The amici states' position is that a competent person has a constitutionally protected interest in refusing unwanted medical treatment.
Attorney General Wilson joined in this brief alongside the states of Texas, Alabama, Alaska, Arkansas, Idaho, Iowa, Kansas, Louisiana, Montana, Nebraska, and Utah.
You can read the brief here.
***
Original text here: https://www.scag.gov/about-the-office/news/attorney-general-alan-wilson-opposes-government-mandated-covid-vaccinations/
ATTORNEY GENERAL RAOUL JOINS ILLINOIS COALITION AGAINST DOMESTIC VIOLENCE TO HIGHLIGHT RING COLLABORATION
CHICAGO, Illinois, Feb. 2 -- Illinois Attorney General Kwame Raoul issued the following news release:
* * *
ATTORNEY GENERAL RAOUL JOINS ILLINOIS COALITION AGAINST DOMESTIC VIOLENCE TO HIGHLIGHT RING COLLABORATION
*
Partnership Includes 1,000 Ring Cameras, $25,000 Donation Supporting Domestic Violence Survivors
Chicago - Attorney General Kwame Raoul today joined officials from Amazon and the Illinois Coalition Against Domestic Violence (ICADV) to announce a collaboration with Ring, an Amazon company, to support domestic violence survivors with technology and safety tools.
Through this partnership,
... Show Full Article
CHICAGO, Illinois, Feb. 2 -- Illinois Attorney General Kwame Raoul issued the following news release:
* * *
ATTORNEY GENERAL RAOUL JOINS ILLINOIS COALITION AGAINST DOMESTIC VIOLENCE TO HIGHLIGHT RING COLLABORATION
*
Partnership Includes 1,000 Ring Cameras, $25,000 Donation Supporting Domestic Violence Survivors
Chicago - Attorney General Kwame Raoul today joined officials from Amazon and the Illinois Coalition Against Domestic Violence (ICADV) to announce a collaboration with Ring, an Amazon company, to support domestic violence survivors with technology and safety tools.
Through this partnership,ICADV has received and equally distributed 1,000 Ring X Line Devices with a basic protect subscription to domestic violence survivors across all 102 Illinois counties. Ring also donated $25,000 during Domestic Violence Awareness Month in October to help support ICADV's mission and ongoing impact across the state.
"Our work to protect survivors of violent crime, including domestic violence, is some of the most important work my office does," Raoul said. "Survivors of domestic violence deserve to feel secure, which is why this collaboration with ICADV and Amazon is so important. These Ring cameras can offer peace of mind to the survivor who wants to know who is on the other side of the door before opening it or who wants to make sure a protection order is not being violated."
The ICADV is the federally designated, statewide coalition of domestic violence services providers for the state of Illinois and serves as the statewide voice for domestic violence advocacy, awareness, and prevention. With over 60 member organizations located in all 102 counties, ICADV's member agencies provide services to domestic violence survivors and their families throughout Illinois.
"For nearly 50 years, the ICADV has served as the statewide leader in domestic violence advocacy and awareness. ICADV is honored to partner with Attorney General Raoul and Amazon to support the safety and well-being of survivors across the state through generously donated Ring cameras," said Carrie Boyd, ICADV CEO and President. "The innovative technology of Ring cameras provides not only peace of mind for survivors but also assists in the prevention of further harm. With domestic violence homicides having increased by approximately 140% in the last several years, while other violent crimes have decreased, this public safety measure is needed now more than ever. We are incredibly grateful to our attorney general and Amazon for their commitment to helping keep survivors and our communities safe."
To date, Ring has donated over 35,000 Ring video doorbells and outdoor cameras to over 800 nonprofit organizations across the country and federally recognized tribal organizations whose primary mission is to support domestic violence survivors. Organizations provide these devices to survivors who are interested in using them as a part of their safety planning.
"At Ring, we believe in making neighborhoods safer and making technology accessible to everyone," said Raquel Medrano, Amazon Public Policy. "Since 2021, we've supported organizations that support domestic violence survivors with technology and tools that help provide an extra layer of peace of mind. We are proud to team up with ICADV and learn alongside them to ensure that Amazon technology continues to support the needs of survivors. We hope this donation will help support community safety throughout Illinois."
During fiscal year 2026, the Illinois Attorney General's office approved over $5.5 million in grant funds for 78 agencies across the state that provide a host of services, such as support groups and food and clothing assistance, to domestic violence survivors. The office also assists survivors with reimbursements for expenses incurred because of the crime, such as counseling, medical costs and lost earnings for missed work. Raoul's office trains Sexual Assault Nurse Examiners (SANEs) to provide holistic care in a trauma-informed, victim-centered manner.
In 2025, Raoul's office received over 250 new applicants to the Address Confidentiality Program, which provides a substitute address for survivors of domestic violence, sexual assault, human trafficking and stalking. Government agencies will then substitute a survivor's home, school or work addresses when creating public records, preventing perpetrators from using publicly available documents to locate victims. By the end of 2025, there were nearly 600 active participants residing in 381 households located in 44 Illinois counties.
Those needing assistance can contact Raoul's Violence Prevention and Crime Victim Services Division by visiting the Illinois Attorney General 's website or by calling 1-800-228-3368. Individuals with hearing or speech disabilities can connect by using the 7-1-1 relay service.
***
Original text here: https://www.illinoisattorneygeneral.gov/news/story/attorney-general-raoul-joins-illinois-coalition-against-domestic-violence-to-highlight-ring-collaboration-2-2-26
ATTORNEY GENERAL RAOUL ANNOUNCES $17.85 MILLION SETTLEMENT WITH LANNETT AND BAUSCH OVER CONSPIRACIES TO INFLATE PRICES, LIMIT COMPETITION
CHICAGO, Illinois, Feb. 2 -- Illinois Attorney General Kwame Raoul issued the following news release:
* * *
ATTORNEY GENERAL RAOUL ANNOUNCES $17.85 MILLION SETTLEMENT WITH LANNETT AND BAUSCH OVER CONSPIRACIES TO INFLATE PRICES, LIMIT COMPETITION
*
Raoul and Majority of Coalition also File New Lawsuit Against Novartis for Same Actions
Chicago - Attorney General Kwame Raoul joined a bipartisan coalition of 48 states and territories announcing two additional settlements with Lannett Company Inc. and Bausch Health US LLC and Bausch Health Americas Inc., totaling $17.85 million to resolve allegations
... Show Full Article
CHICAGO, Illinois, Feb. 2 -- Illinois Attorney General Kwame Raoul issued the following news release:
* * *
ATTORNEY GENERAL RAOUL ANNOUNCES $17.85 MILLION SETTLEMENT WITH LANNETT AND BAUSCH OVER CONSPIRACIES TO INFLATE PRICES, LIMIT COMPETITION
*
Raoul and Majority of Coalition also File New Lawsuit Against Novartis for Same Actions
Chicago - Attorney General Kwame Raoul joined a bipartisan coalition of 48 states and territories announcing two additional settlements with Lannett Company Inc. and Bausch Health US LLC and Bausch Health Americas Inc., totaling $17.85 million to resolve allegationsthat these companies engaged in widespread, long-running conspiracies to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade with regard to numerous generic prescription drugs.
Raoul is urging Illinois consumers who purchased a generic prescription drug listed here between May 2009 and December 2019 to determine their eligibility by calling 1-866-290-0182 (Toll-Free), emailing info@AGGenericDrugs.com or visiting www.AGGenericDrugs.com.
"This settlement is another victory in holding drug companies accountable for engaging in practices to maximize profits at the expense of Illinoisans' health and pocketbooks," Raoul said. "I will continue to stand with my fellow attorneys general to stop pharmaceutical companies and executives from continuing unlawful and unfair tactics that fuel health care inequity in Illinois and around the country."
As part of the settlement agreements, both companies have agreed to cooperate in ongoing multistate litigation against 30 corporate defendants and 25 individual executives. Both companies have further agreed to a series of internal reforms to ensure fair competition and compliance with antitrust laws.
Also today, Raoul joined 41 states and territories in filing a new lawsuit against Novartis and its generic subsidiary Sandoz, alleging a systemic campaign to conspire with other generic manufacturers to fix prices, allocate markets and rig bids for 31 different generic drugs. The complaint further alleges that Novartis took steps to fraudulently transfer and drain assets from Sandoz and spin off Sandoz to shield Novartis from liability in the three previously filed state antitrust complaints against the company.
This is the latest legal challenge by Raoul and the coalition. The cases stem from a series of investigations built on evidence from several cooperating witnesses at the core of different conspiracies, a massive document database comprised of over 20 million documents, and a phone records database containing millions of call-detail records and contact information for over 600 sales-and-pricing individuals in the generics industry.
The first complaint, filed in 2016, included Heritage and 17 other corporate defendants, two individual defendants and 15 generic drugs. The second complaint was filed in 2019 against Teva Pharmaceuticals and 19 of the nation's largest generic drug manufacturers. The complaint names 16 individual senior executive defendants. The third complaint, to be tried first, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and names 26 corporate defendants and 10 individual defendants.
The multistate coalition has reached a series of settlements with several executives and companies. Seven pharmaceutical executives have entered into settlement agreements, as well as Apotex and Heritage, which paid $39.1 million and $10 million, respectively.
Joining Raoul in this settlement are the attorneys general of Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
***
Original text here: https://www.illinoisattorneygeneral.gov/news/story/attorney-general-raoul-announces-1785-million-settlement-with-lannett-and-bausch-over-conspiracies-to-inflate-prices-limit-competition
AG Sunday Announces $17.85M National Settlement Over Generic Drug Price-Fixing; Pennsylvanians are Eligible for Compensation
HARRISBURG, Pennsylvania, Feb. 2 -- Pennsylvania Attorney General David W. Sunday issued the following news:
* * *
AG Sunday Announces $17.85M National Settlement Over Generic Drug Price-Fixing; Pennsylvanians are Eligible for Compensation
*
HARRISBURG - Attorney General Dave Sunday announced that Pennsylvania has joined a multistate coalition in securing $17.85 million in settlements with generic drug manufacturers Lannett Company, Inc. and Bausch Health over allegations the companies conspired to inflate prices and restrict competition.
The settlements resolve claims that the companies
... Show Full Article
HARRISBURG, Pennsylvania, Feb. 2 -- Pennsylvania Attorney General David W. Sunday issued the following news:
* * *
AG Sunday Announces $17.85M National Settlement Over Generic Drug Price-Fixing; Pennsylvanians are Eligible for Compensation
*
HARRISBURG - Attorney General Dave Sunday announced that Pennsylvania has joined a multistate coalition in securing $17.85 million in settlements with generic drug manufacturers Lannett Company, Inc. and Bausch Health over allegations the companies conspired to inflate prices and restrict competition.
The settlements resolve claims that the companiesparticipated in long-running schemes to manipulate prices of certain generic prescription drugs sold nationwide, including Pennsylvania, between May 2009 and December 2019. As part of the agreements, both companies will cooperate with ongoing litigation against additional pharmaceutical manufacturers and executives, and implement internal reforms to comply with antitrust laws.
"Pennsylvania consumers rely on generic medications to keep health care affordable," Attorney General Sunday said. "When companies illegally raise prices and eliminate competition, families, seniors, and patients on fixed incomes pay the price. This settlement helps return money to Pennsylvanians who were overcharged and sends a clear message that drug companies will be held accountable for putting profits over people."
The Lannett and Bausch settlements follow earlier multistate agreements, totaling $49.1 million. Pennsylvania continues to participate in ongoing antitrust litigation against numerous pharmaceutical manufacturers, with the first trial anticipated in late 2026.
Also today, a coalition of 42 states and territories, including Pennsylvania, will file a new lawsuit against pharmaceutical companies Novartis and its generic subsidiary Sandoz. The complaint alleges the companies engaged in a coordinated scheme to fix prices, allocate markets, and rig bids for dozens of generic prescription drugs sold nationwide.
Pennsylvanians who purchased generic prescription drugs manufactured by Lannett or Bausch between May 1, 2009, and December 31, 2019, may be eligible for compensation.
To learn more or check eligibility, call 1-866-290-0182, email in ** @ ********* gs.com, or visit www.AGGeneric Drugs.com.
The following states and territories that joined Pennsylvania in today's settlements with Lannett and Bausch include Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
States and territories filing the new lawsuit against Novartis and Sandoz include Alaska, Arizona, California, Connecticut, Colorado, Delaware, District of Columbia, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Dakota, Tennessee, Vermont, U.S. Virgin Islands, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
***
Original text here: https://www.attorneygeneral.gov/taking-action/ag-sunday-announces-17-85m-national-settlement-over-generic-drug-price-fixing-pennsylvanians-are-eligible-for-compensation/
